Patents Assigned to LOCATE THERAPEUTICS LIMITED
-
Publication number: 20210290818Abstract: The invention relates to a method of forming a tissue scaffold material for controlled release of an agent in situ, or tissue regeneration, and a system of controlling scaffold and scaffold setting properties using various constituents, such as ceramics and/or plasticisers, and carriers. The invention further relates to scaffold material, scaffolds, and kits, and the use of such scaffold material and scaffolds in methods of treatment.Type: ApplicationFiled: November 13, 2020Publication date: September 23, 2021Applicant: LOCATE THERAPEUTICS LIMITEDInventors: Antonio LEONARDI, Helen C. COX, Siobhan CAREY, Charles MATTHEWS, Alexander LOMAS, Kevin M. SHAKESHEFF, Robin A. QUIRK
-
Patent number: 10933167Abstract: A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.Type: GrantFiled: August 9, 2018Date of Patent: March 2, 2021Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Patrick Ginty, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Publication number: 20200368387Abstract: The invention relates to a scaffold material composition for forming a solid tissue scaffold, the composition comprising a plurality of hollow polymer pellets, each pellet comprising an open hollow extending through the pellet, and wherein the plurality of hollow polymer pellets are capable of interlinking and setting into a solid scaffold. The invention further relates to associated compositions, uses, method of treatment and kits associated with such material.Type: ApplicationFiled: February 12, 2018Publication date: November 26, 2020Applicant: Locate Therapeutics LimitedInventors: Antonio LEONARDI, Helen Celia COX, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Publication number: 20200093956Abstract: The invention relates to a method of forming a tissue scaffold material for controlled release of an agent in situ, or tissue regeneration, and a system of controlling scaffold and scaffold setting properties using various constituents, such as ceramics and/or plasticisers, and carriers. The invention further relates to scaffold material, scaffolds, and kits, and the use of such scaffold material and scaffolds in methods of treatment.Type: ApplicationFiled: March 23, 2017Publication date: March 26, 2020Applicant: LOCATE THERAPEUTICS LIMITEDInventors: Antonio LEONARDI, Helen C. COX, Siobhan CAREY, Charles MATTHEWS, Alexander LOMAS, Kevin M. SHAKESHEFF, Robin A. QUIRK
-
Patent number: 10232087Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: GrantFiled: March 29, 2004Date of Patent: March 19, 2019Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Richard Melville France, Robin Andrew Quirk
-
Patent number: 10195309Abstract: A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.Type: GrantFiled: February 1, 2008Date of Patent: February 5, 2019Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Patrick Ginty, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Patent number: 10086113Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: GrantFiled: March 29, 2004Date of Patent: October 2, 2018Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Richard Melville France, Robin Andrew Quirk
-
Patent number: 9486558Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: GrantFiled: May 8, 2008Date of Patent: November 8, 2016Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Richard Melville France, Robin Andrew Quirk
-
Publication number: 20160175482Abstract: An injectable agent delivery system comprising a composition that comprises: an agent for sustained delivery located within discrete particles; and an injectable scaffold material comprising discrete particles which are capable of interacting to form a scaffold, and uses thereof.Type: ApplicationFiled: August 8, 2014Publication date: June 23, 2016Applicant: LOCATE THERAPEUTICS LIMITEDInventors: Robin Andrew QUIRK, Helen Celia COX, Kevin Morris SHAKESHEFF